ストックスクリーナーアプリを入手
7.52
2.31%
0.17
前日終値:
$7.35
開ける：
$7.4
24時間の取引高:
261.14K
Relative Volume:
0.43
時価総額：
$640.16M
収益：
$81.18M
当期純損益:
$-80.94M
株価収益率:
-6.368
EPS:
-1.1809
ネットキャッシュフロー:
$-55.15M
1週間 パフォーマンス:
+8.51%
1か月 パフォーマンス:
-9.83%
6か月 パフォーマンス:
+54.73%
1年 パフォーマンス:
+79.05%
1日の値動き範囲:
$0.00
$0.00
1週間の範囲:
$6.90
$7.53
52週間の値動き範囲:
$3.83
$8.98
Sophia Genetics Sa Stock (SOPH) Company Profile
Compare SOPH vs VEEV, TEM, BTSG, HNGE, HQY
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SOPH
Sophia Genetics Sa
|
7.52 | 640.16M | 81.18M | -80.94M | -55.15M | -1.1809 |
VEEV
Veeva Systems Inc
|
318.18 | 51.52B | 3.32B | 941.65M | 1.64B | 5.6161 |
TEM
Tempus Ai Inc
|
67.16 | 12.24B | 1.36B | -302.91M | -219.93M | -1.7182 |
BTSG
Brightspring Health Services Inc
|
58.88 | 11.65B | 13.65B | 169.86M | 412.12M | 1.0758 |
HNGE
Hinge Health Inc
|
111.71 | 9.01B | 646.34M | -512.40M | 202.76M | -6.6871 |
HQY
Healthequity Inc
|
103.75 | 8.58B | 1.34B | 230.70M | 440.96M | 2.6695 |
Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-07-20 | 開始されました | H.C. Wainwright | Buy |
| 2024-12-18 | 開始されました | Craig Hallum | Buy |
| 2024-08-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2024-06-27 | 開始されました | Guggenheim | Buy |
| 2023-11-29 | 開始されました | RBC Capital Mkts | Outperform |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-01-03 | 開始されました | BTIG Research | Buy |
| 2022-11-23 | 開始されました | Credit Suisse | Neutral |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-08-17 | 開始されました | Cowen | Outperform |
| 2021-08-17 | 開始されました | Credit Suisse | Outperform |
| 2021-08-17 | 開始されました | JP Morgan | Overweight |
| 2021-08-17 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Sophia Genetics Sa (SOPH) 最新ニュース
SOPHiA GENETICS (SOPH) Rises 3.26% to $7.29, Holding the Middle of Its Recent Trading BandAnalyst Downgrade Signals - https://www.siam.in/
Form 4 SOPHiA GENETICS SA: Zhenyu Xu (Chief Scientific Officer) For: 13 October - Investing.com Nigeria
Jurgi Camblong Executes Sale of 8,500 SOPHiA GENETICS Shares on October 12 Under Rule 10b5-1 Plan - Kalkine Media
Form 144 SOPHIA GENETICS SA For: 12 October By Investing.com - Investing.com Nigeria
Form 144 SOPHIA GENETICS SA For: 12 October By Investing.com - Investing.com UK
SOPHiA GENETICS SA Ordinary Shares (SOPH) Stock Price: Oct 7 Close $7.15 - Gotrade
SOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology - Yahoo Finance
How Is SOPHiA GENETICS Advancing AI in Healthcare? - Kalkine Media
SOPHiA GENETICS CSO Kevin Puylaert Sells 216 Shares for RSU Tax Withholding on October 5, 2026 - Kalkine Media
SOPHiA GENETICS CMO Philippe Menu Sells 7,394 Shares to Cover RSU Tax Withholdings - Kalkine Media
SOPHiA GENETICS (NASDAQ:SOPH) Insider Well Daan Van Sells 6,168 Shares of Company Stock - MarketBeat
Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells 7,394 Shares of Company Stock - MarketBeat
Tax withholding drives legal chief’s 6,168-share sale at SOPHiA GENETICS (SOPH) - Stock Titan
Form 4 SOPHiA GENETICS SA For: 7 October By Investing.com - Investing.com South Africa
SOPHiA GENETICS Director Ross J. Muken Files Form 144 for Sale of 9,838 Shares Under 10b5-1 Plan - Kalkine Media
An officer plans to sell 19,394 common shares in SOPHiA GENETICS (SOPH). - Stock Titan
An officer proposes selling 6,168 SOPHiA GENETICS (NASDAQ: SOPH) shares after stock grants vest. - Stock Titan
9,838 shares are proposed for sale by Ross J. Muken at SOPHiA GENETICS (SOPH), valued at $79.4K. - Stock Titan
Officer George Cardoza proposes selling 1,592 SOPHiA GENETICS (SOPH) common shares. - Stock Titan
Founder shares feature in Jurgi Camblong’s proposed $530K SOPHiA GENETICS (Nasdaq: SOPH) sale. - Stock Titan
Officer Manuela Valente proposes selling 4,240 SOPHiA GENETICS (SOPH) shares. - Stock Titan
SOPHiA GENETICS CEO Ross Muken Sells 422 Shares to Cover RSU Tax Withholding - Kalkine Media
SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional Shares - Eastern Progress
Officer at SOPHiA GENETICS (NASDAQ: SOPH) lines up 774-share sale after 10b5-1 trades - Stock Titan
Planned sale of 422 SOPHiA GENETICS (SOPH) shares disclosed under Rule 144 - Stock Titan
SOPHiA GENETICS (SOPH) Moves 7.0% Higher: Will This Strength Last? - Yahoo Finance
SOPHiA GENETICS (NASDAQ: SOPH) Insider Xu Zhenyu Retains 552,887 Shares Following Sale - Kalkine Media
SOPHiA GENETICS SA (NASDAQ: SOPH) Executive Menu Philippe Disposes of 5,000 Shares at $7.88 Each - Kalkine Media
SOPHiA GENETICS CSO Xu Zhenyu Sells 4,000 Shares Under Rule 10b5-1 Plan - Kalkine Media
SOPHiA GENETICS (NASDAQ:SOPH) Sees Strong Trading VolumeShould You Buy? - marketbeat.com
SOPHiA GENETICS Insider Van Well Daan Sells 6,168 Shares at $7.63 Each (NASDAQ: SOPH) - Kalkine Media
Officer at SOPHiA GENETICS (NASDAQ: SOPH) to sell 6,168 shares - Stock Titan
SOPHiA GENETICS SA (NASDAQ:SOPH) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) Director Sells $50,812.50 in Stock - MarketBeat
SOPHiA GENETICS Director Kathy L. Hibbs Sells 6,250 Shares via 10b5-1 Trading Plan - Kalkine Media
SOPHiA GENETICS (NASDAQ:SOPH) Shares Down 8.3%Time to Sell? - MarketBeat
Maven Securities LTD Invests $866,000 in SOPHiA GENETICS SA $SOPH - MarketBeat
SOPHiA GENETICS (SOPH) Stock Sees Modest Fair Value Lift After Q2 Guidance Raise - Yahoo Finance
SOPHiA GENETICS (NASDAQ:SOPH): Is Volume Signaling A Shift? - Kalkine Media
SOPHiA GENETICS (NASDAQ:SOPH) Sees Large Volume IncreaseHere's Why - marketbeat.com
SOPHiA GENETICS CSO Zhenyu Xu Sells 10,000 Shares Under Rule 10b5-1 Plan - Kalkine Media
Zhenyu Xu Sells 10,000 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) Stock Price Down 5%Here's Why - MarketBeat
Sophia Genetics SA (SOPH) Peer Comparison – Compare with Others - Value Research
SOPHiA GENETICS (NASDAQ: SOPH) officer to sell 14K founder shares - Stock Titan
SOPHiA GENETICS Director Kathy L. Hibbs Sells 6,250 Shares Under Rule 10b5-1 Plan - Kalkine Media
SOPHiA GENETICS CTO Abhimanyu Verma Executes Sale of 10,000 Shares in August 2026 - Kalkine Media
SOPHiA GENETICS (NASDAQ: SOPH) director plans $158K stock sale - Stock Titan
SOPHiA (SOPH) Earnings Update: The Available Earnings Metric Delivers a Miss in the Available Record; Share Move: Shares Move Lower 2.31% in Latest TradingEarnings Stability Report - dars.gov.et
SOPHiA GENETICS (NASDAQ:SOPH) Sees Strong Trading VolumeHere's What Happened - marketbeat.com
Sophia Genetics Sa (SOPH) 財務データ
収益
当期純利益
現金流量
EPS
Sophia Genetics Sa (SOPH) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Xu Zhenyu | Chief Scientific Officer |
Oct 13 '26 |
Sale |
7.18 |
4,000 |
28,727 |
541,493 |
| Camblong Jurgi | Executive Chairman |
Oct 12 '26 |
Sale |
7.26 |
8,500 |
61,671 |
3,387,150 |
| ROSS J MUKEN | Director |
Oct 05 '26 |
Proposed Sale |
8.07 |
9,838 |
79,393 |
0 |
| PHILIPPE MENU | Officer |
Oct 05 '26 |
Proposed Sale |
8.07 |
22,394 |
180,720 |
0 |
| MANUELA VALENTE | Officer |
Oct 05 '26 |
Proposed Sale |
8.07 |
4,240 |
34,217 |
0 |
| GEORGE CARDOZA | Officer |
Oct 05 '26 |
Proposed Sale |
8.07 |
1,592 |
12,847 |
0 |
| JURGI CAMBLONG | Director |
Oct 05 '26 |
Proposed Sale |
8.07 |
65,672 |
529,973 |
0 |
| Valente Manuela | Chief People Officer |
Oct 05 '26 |
Sale |
8.13 |
4,240 |
34,487 |
206,210 |
| Verma Abhimanyu | Chief Technology Officer |
Oct 05 '26 |
Sale |
8.12 |
5,284 |
42,929 |
166,887 |
| Van Well Daan | Chief Legal Officer |
Oct 05 '26 |
Sale |
8.12 |
6,168 |
50,100 |
332,716 |
0.14%
5.62%
大文字化:
|
ボリューム (24 時間):